Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Leukemia

  Free Subscription


Articles published in Leuk Res

Retrieve available abstracts of 378 articles:
HTML format
Text format



Single Articles


    March 2010
  1. BEST A , Matheson E, Minto L, Hall AG, et al
    Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  2. NOH EK , Kim H, Park MJ, Baek JH, et al
    Gefitinib enhances arsenic trioxide (AS(2)O(3))-induced differentiation of acute promyelocytic leukemia cell line.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  3. ZAMECNIKOVA A , Al Bahar S, Elshinnawy SE
    Genomic instability and rapid clinical course in adult T-cell lymphoma/leukemia patient.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  4. MONJANEL H , Hourioux C, Arbion F, Colombat P, et al
    Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  5. ERICKSON-MILLER CL , Kirchner J, Aivado M, May R, et al
    Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  6. ORGANISTA-NAVA J , Gomez-Gomez Y, Saavedra-Herrera MV, Rivera-Ramirez AB, et al
    Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  7. MURANYI AL , Dedhar S, Hogge DE
    Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  8. SONG X , Gong S, Chen J, Gao L, et al
    ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  9. HAN S , Lee KM, Park SK, Lee JE, et al
    Genome-wide association study of childhood acute lymphoblastic leukemia in Korea.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  10. NGAMPHAIBOON N , Sweeney R, Wetzler M, Wang ES, et al
    Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  11. KAPOOR G , Sinha R, Naithani R, Chandgothia M, et al
    Thiopurine S-methyltransferase gene polymorphism and 6-mercaptopurine dose intensity in Indian children with acute lymphoblastic leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  12. LANGABEER SE , Crampe M, Haslam K, Kelly J, et al
    Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  13. CARULLI G , Cannizzo E, Ottaviano V, Cervetti G, et al
    Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  14. LIM WS , Tardi PG, Dos Santos N, Xie X, et al
    Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  15. WANG C , Chen Z, Li Z, Cen J, et al
    The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  16. KANOJIA D , Garg M, Saini S, Agarwal S, et al
    Sperm associated antigen 9 expression and humoral response in chronic myeloid leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  17. KIM HP , Frankel AE, Hogge DE
    A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  18. CHEN F , Li L, Ma D, Yan S, et al
    Imatinib achieved complete cytogenetic response in a CML patient received 32-year indirubin and its derivative treatment.
    Leuk Res. 2010;34:e75-7.
    PubMed     Text format     Related articles   


  19. PICH A , Godio L
    Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) and JAK2(V617F) mutation transformed to acute myeloid leukaemia with chromosomal evolution including monosomy 7.
    Leuk Res. 2010;34:e69-70.
    PubMed     Text format     Related articles   


  20. OWEN C
    Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML).
    Leuk Res. 2010;34:141-2.
    PubMed     Text format     Related articles   


  21. TONG WG , Wei Y, Stevenson W, Kuang SQ, et al
    Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor.
    Leuk Res. 2010;34:221-8.
    PubMed     Text format     Related articles    Abstract available


  22. MAHMUD M , Stebbing J
    Epigenetic modifications in AML and MDS.
    Leuk Res. 2010;34:139-40.
    PubMed     Text format     Related articles   


    January 2010
  23. DAMIANI D , Tiribelli M, Michelutti A, Geromin A, et al
    Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  24. LITZINGER MT , Foon KA, Tsang KY, Schlom J, et al
    Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  25. ZHANG XH , Zhang R, Li Y
    Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: Case report and review of literature.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  26. NICHOLSON L , Hall AG, Redfern CP, Irving J, et al
    NFkappaB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  27. BEITINJANEH A , Jang S, Roukoz H, Majhail NS, et al
    Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  28. GUPTA N , Gupta SK, Rathi S, Sharma SK, et al
    Acute lymphoblastic leukemia presenting as non-oliguric renal failure and hypertension.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  29. TARNANI M , Laurenti L, Longo PG, Piccirillo N, et al
    The proliferative response to CpG-ODN stimulation predicts PFS, TTT and OS in patients with chronic lymphocytic leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  30. YI HS , Sym SJ, Park J, Cho EK, et al
    Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  31. WIDMER N , Gotta V, Haouala A, Decosterd LA, et al
    Tyrosine kinase inhibitors concentration monitoring in chronic myeloid leukemia.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  32. NAGAI T , Ohmine K, Fujiwara SI, Uesawa M, et al
    Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  33. PLUTA A , Wrzesien-Kus A, Cebula-Obrzut B, Wolska A, et al
    Influence of high expression of Smac/DIABLO protein on the clinical outcome in acute myeloid leukemia patients.
    Leuk Res. 2010.
    PubMed     Text format     Related articles    Abstract available


  34. ASANO H , Yamamoto G, Hosoi M, Takahashi T, et al
    Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  35. SMOLEJ L , Belada D, Cermanova M, Maisnar V, et al
    Severe anemia caused by combination of autoimmune hemolysis, pure red cell aplasia and massive bone marrow infiltration in an elderly patient with chronic lymphocytic leukemia: Successful treatment with rituximab.
    Leuk Res. 2010.
    PubMed     Text format     Related articles   


  36. YANG YL , Lin SR, Chen JS, Lin SW, et al
    Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.
    Leuk Res. 2010;34:18-23.
    PubMed     Text format     Related articles    Abstract available


  37. ERIKSTEIN BS , McCormack E, Tronstad KJ, Schwede F, et al
    Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB.
    Leuk Res. 2010;34:77-84.
    PubMed     Text format     Related articles    Abstract available


  38. MARIANI S , Tornaghi L, Sassone M, Basciani S, et al
    Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia.
    Leuk Res. 2010;34:e5-7.
    PubMed     Text format     Related articles   


  39. GAFTER-GVILI A , Ram R, Gafter U, Shpilberg O, et al
    Renal failure associated with tyrosine kinase inhibitors--case report and review of the literature.
    Leuk Res. 2010;34:123-7.
    PubMed     Text format     Related articles    Abstract available


  40. LYONS R , Williams O, Morrow M, Sebire N, et al
    The RAC specific guanine nucleotide exchange factor Asef functions downstream from TEL-AML1 to promote leukaemic transformation.
    Leuk Res. 2010;34:109-15.
    PubMed     Text format     Related articles    Abstract available


  41. GU W , Hu S, Chen Z, Qiu G, et al
    High expression of WT1 gene in acute myeloid leukemias with more predominant WT1+17AA isoforms at relapse.
    Leuk Res. 2010;34:46-9.
    PubMed     Text format     Related articles    Abstract available


    December 2009
  42. SEVER M , Verstovsek S, Erasmus J Jr, Mattiuzzi GN, et al
    Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: Case report and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  43. TAVOLARO S , Chiaretti S, Messina M, Peragine N, et al
    Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  44. CUI L , Li Z, Wu M, Li W, et al
    Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  45. DASANU CA , Bauer F
    Large granular lymphocytic (LGL) leukemia in an adult with Down syndrome (47,XX,+21).
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  46. CAO J , Chen C, Zeng L, Li L, et al
    Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  47. BRECCIA M , Muscaritoli M, Cannella L, Loglisci G, et al
    Modifications of fasting glucose values as first sign of resistance in chronic myeloid leukemia chronic phase patients during imatinib treatment.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  48. KAKIMOTO T , Takahashi Y, Watanabe H, Matsuzawa M, et al
    Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  49. STRATHDEE G , Ferguson S, Sim A, Brown R, et al
    DNA methylation does not regulate JUNB expression in CML: Comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366].
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  50. MARQUES DS , Sandrini JZ, Boyle RT, Marins LF, et al
    Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  51. KARP JE , Blackford A, Smith BD, Alino K, et al
    Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  52. CHANTEPIE SP , Vaur D, Grunau C, Salaun V, et al
    ZAP-70 intron1 DNA methylation status: Determination by pyrosequencing in B chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  53. GUASTAFIERRO S , Falcone U, Celentano M, Carbone A, et al
    Chronic lymphocytic leukemia presenting with symptomatic peritoneal infiltration.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  54. DA COSTA SV , Roela RA, Junqueira MS, Arantes C, et al
    The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  55. LIU Y , Zhang X, Li ZJ, Chen XH, et al
    Up-regulation of Cx43 expression and GJIC function in acute leukemia bone marrow stromal cells post-chemotherapy.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  56. ZHAO X , Yang L, Hu J, Ruan J, et al
    miR-138 might reverse multidrug resistance of leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  57. GANDEMER V , Aubry M, Roussel M, Rio AG, et al
    CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: Proposal for an accelerated diagnostic flowchart.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  58. DOVAT S , Payne KJ
    Tumor suppression in T cell leukemia-The role of Ikaros.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  59. SANDOVAL C
    Pediatric acute lymphoblastic leukemia: There is no TEL-ing what wonders lie ahead.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  60. BERNARDESCHI P , Pirrotta MT, Montenora I, Giustarini G, et al
    Clonal evolution at leukemic relapse of multiple myeloma (secondary plasma cell leukemia) responding to re-treatment with bortezomib-based therapy. A case record.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  61. HAMBLIN TJ
    Just exactly how common is CLL?
    Leuk Res. 2009;33:1452-3.
    PubMed     Text format     Related articles   


  62. MOURTADA-MAARABOUNI M , Williams GT
    Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.
    Leuk Res. 2009;33:1539-51.
    PubMed     Text format     Related articles    Abstract available


  63. USTAALIOGLU BB , Bilici A, Seker M, Gumus M, et al
    Bilateral primary small lymphocytic lymphoma of the lacrimal sac and review of the literature.
    Leuk Res. 2009;33:e184-5.
    PubMed     Text format     Related articles   


  64. HARAGUCHI K , Ohno N, Tokunaga M, Tokunaga M, et al
    Masked t(15;17) APL with the insertion of PML-RARalpha fusion gene in 4q21.
    Leuk Res. 2009;33:1552-5.
    PubMed     Text format     Related articles    Abstract available


  65. PARMA M , Colnaghi F, Colombo A, Elli E, et al
    A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript.
    Leuk Res. 2009;33:e175-7.
    PubMed     Text format     Related articles   


  66. KUAN JW , Pathmanathan R, Chang KM, Tan SM, et al
    Aleukemic bcr-abl positive granulocytic sarcoma.
    Leuk Res. 2009;33:1574-7.
    PubMed     Text format     Related articles    Abstract available


  67. SHAMI PJ , Maciag AE, Eddington JK, Udupi V, et al
    JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).
    Leuk Res. 2009;33:1525-9.
    PubMed     Text format     Related articles    Abstract available


    October 2009
  68. DE LAVALLADE H , Finetti P, Carbuccia N, Khorashad JS, et al
    A gene expression signature of primary resistance to imatinib in chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  69. RAVANDI F , Kantarjian H, Faderl S, Garcia-Manero G, et al
    Outcome of patients with FLT3-mutated acute myeloid leukemia in first relapse.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  70. SCRIDELI CA , Cortez MA, Yunes JA, Queiroz RG, et al
    mRNA expression of matrix metalloproteinases (MMPs) 2 and 9 and tissue inhibitor of matrix metalloproteinases (TIMPs) 1 and 2 in childhood acute lymphoblastic leukemia: Potential role of TIMP1 as an adverse prognostic factor.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  71. HAYES GM , Busch R, Voogt J, Siah IM, et al
    Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: Validation of a simplified method suitable for multi-center clinical studies.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  72. BOREL C , Huynh A, Chaufour X, Lousteau O, et al
    Uterine chloroma, aortic thrombus and CALM/AF10 acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  73. YAMAMOTO M , Kuroda J, Uchiyama H, Kobayashi T, et al
    Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  74. MATONDO M , Bousquet-Dubouch MP, Gallay N, Uttenweiler-Joseph S, et al
    Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: A correlation with the proteasome status.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  75. PAQUETTE RL , Nicoll J, Chalukya M, Gondek L, et al
    Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  76. PEPPER C
    APRIL showers put a spring in the step of CLL cells.
    Leuk Res. 2009;33:1306-7.
    PubMed     Text format     Related articles   


  77. HUGHES PJ , Brown G
    Interplay between signalling pathways mediates 1,25alpha-dihydroxyvitamin D3-driven monocytic differentiation--JNKs are important.
    Leuk Res. 2009;33:1298-300.
    PubMed     Text format     Related articles   


  78. SCHNYDER S , Du NT, Le HB, Singh S, et al
    Estrogen treatment induces MLL aberrations in human lymphoblastoid cells.
    Leuk Res. 2009;33:1400-4.
    PubMed     Text format     Related articles    Abstract available


  79. PEKOVA S , Ivanek R, Dvorak M, Rueggeberg S, et al
    Molecular variability of FLT3/ITD mutants and their impact on the differentiation program of 32D cells: implications for the biological properties of AML blasts.
    Leuk Res. 2009;33:1409-16.
    PubMed     Text format     Related articles    Abstract available


  80. HAN Y , Xue Y, Zhang J, Pan J, et al
    Y-chromosome loss as the sole karyotypic anomaly with 3'RARalpha submicroscopic deletion in a case of M3r subtype of acute promyelocytic leukemia.
    Leuk Res. 2009;33:1433-5.
    PubMed     Text format     Related articles    Abstract available


  81. CAMPS SM , Chevret S, Levy V
    How to use clinical vignettes in hematology--a pilot survey in the context of chronic lymphocytic leukemia.
    Leuk Res. 2009;33:1328-34.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  82. JEDDI R , Ghedira H, Mnif S, Gouider E, et al
    High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  83. YEH CH , Tseng R, Hannah A, Estrov Z, et al
    Clinical correlation of circulating heat shock protein 70 in acute leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  84. DE CAMPOS MG , Arantes AD, de Oliveira JS, Chauffaille MD, et al
    Chronic myeloid leukemia: A disease of youth in Brazil.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  85. TSAGARAKIS NJ , Kentrou NA, Papadimitriou KA, Pagoni M, et al
    Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  86. YAMAMOTO K , Wakahashi K, Okamura A, Katayama Y, et al
    Two further cases of myelodysplastic syndrome and acute myeloid leukemia with der(5;19)(p10;q10): Association with abnormalities involving chromosomes 12 and 21.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  87. MEDEIROS BC , Kohrt HE, Arber DA, Bangs CD, et al
    Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  88. BRECCIA M , Alimena G
    Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  89. TSCHAN MP , Shan D, Laedrach J, Eyholzer M, et al
    NDRG1/2 expression is inhibited in primary acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  90. WANG LX , Fei XM, Lu YL, Shi XF, et al
    Acute myeloid leukemia initially presenting as hemophagocytic lymphohistiocytosis-A case report and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  91. ZHANG J , Yamada O, Matsushita Y, Chagan-Yasutan H, et al
    Transactivation of human osteopontin promoter by human T-cell leukemia virus type 1-encoded Tax protein.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  92. ABUJAMRA AL , Dos Santos MP, Roesler R, Schwartsmann G, et al
    Histone deacetylase inhibitors: A new perspective for the treatment of leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  93. LABUDA M , Gahier A, Gagne V, Moghrabi A, et al
    Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL).
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  94. ALLEN SL , Kolitz JE, Lundberg AS, Bennett JM, et al
    Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  95. CAOCCI G , S Atzeni, Orru N, Littera R, et al
    Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2(V617F) mutation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  96. SCHNEIDER P , Costa O, Legrand E, Bigot D, et al
    In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  97. XU KH , Lu DP
    Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  98. KACHLANY SC , Schwartz AB, Balashova NV, Hioe CE, et al
    Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  99. UEDA K , Nagai S, Miyashita SI, Kaise T, et al
    Arsenic-induced pericardial and pleural effusion without acute promyelocytic leukemia differentiation syndrome.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  100. SUZUSHIMA H , Wada N, Yamasaki H, Eto K, et al
    Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  101. WANG X , Liu H, Geng L, Zhang X, et al
    Non-therapy-related acute lymphoblastic leukemia with t(9;22)(q34;q11) as a second malignancy: Report of a case and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  102. AWIDI A , Salem II, Najib N, Mefleh R, et al
    Determination of imatinib plasma levels in patients with chronic myeloid leukemia by high performance liquid chromatography-ultraviolet detection and liquid chromatography-tandem mass spectrometry: Methods' comparison.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  103. MCCLURE R , Khoury J, Feldman A, Ketterling R, et al
    Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: A case report and discussion in the context of similar cases.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  104. MORSELLI M , Bandieri E, Zanin R, Buonaccorso L, et al
    Pain and emotional distress in leukemia patients at diagnosis.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  105. KIGUCHI T , Yoshino Y, Yuan B, Yoshizawa S, et al
    Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  106. VALDEZ BC , Li Y, Murray D, Corn P, et al
    5-Aza-2'-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  107. KIM MK , Cho HS, Bae YK, Lee KH, et al
    Nilotinib-induced hyperbilirubinemia: is it a negligible adverse event?
    Leuk Res. 2009;33:e159-61.
    PubMed     Text format     Related articles   


  108. CLARK RE
    Facts and uncertainties in monitoring treatment response in chronic myeloid leukaemia.
    Leuk Res. 2009;33:1151-5.
    PubMed     Text format     Related articles    Abstract available


  109. NARITA M , Watanabe N, Yamahira A, Hashimoto S, et al
    A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naive T cells.
    Leuk Res. 2009;33:1224-32.
    PubMed     Text format     Related articles    Abstract available


  110. USUKI K , Yokoyama K, Nagamura-Inoue T, Ito A, et al
    CD8+ memory T cells predominate over naive T cells in therapy-free CML patients with sustained major molecular response.
    Leuk Res. 2009;33:e164-5.
    PubMed     Text format     Related articles   


  111. GOLOGAN R , Constantinescu G, Georgescu D, Ostroveanu D, et al
    Hypolipemiant besides antileukemic effect of imatinib mesylate.
    Leuk Res. 2009;33:1285-7.
    PubMed     Text format     Related articles    Abstract available


  112. KIM D , Kim DW, Cho BS, Goh HG, et al
    Structural modeling of V299L and E459K Bcr-Abl mutation, and sequential therapy of tyrosine kinase inhibitors for the compound mutations.
    Leuk Res. 2009;33:1260-5.
    PubMed     Text format     Related articles    Abstract available


  113. BOISSEL L , Betancur M, Wels WS, Tuncer H, et al
    Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells.
    Leuk Res. 2009;33:1255-9.
    PubMed     Text format     Related articles    Abstract available


  114. GUNN SR , Bolla AR, Barron LL, Gorre ME, et al
    Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME gene.
    Leuk Res. 2009;33:1276-81.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  115. CENCIC R , Carrier M, Trnkus A, Porco JA Jr, et al
    Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  116. HAMBLIN TJ
    The TCL1 mouse as a model for chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  117. SEMSEI AF , Antal P, Szalai C
    Strengths and weaknesses of gene association studies in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  118. MANSOURI M , Sevov M, Fahlgren E, Tobin G, et al
    Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  119. MONDAL S , Chandra S, Mandal C
    Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  120. WU T , Li ZJ, Qiu LG
    Complications of chronic lymphocytic leukemia: Analysis of 203 cases in China.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  121. HE G , Wu D, Zhang X, Li Y, et al
    Acute T cells lymphoblastic leukemia associated with t(1;19)(q23;p13)/E2A-PBX1 in an adult.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  122. CHEUNG AM , Chow HC, Kwong YL, Liang R, et al
    FLT3/internal tandem duplication subclones in acute myeloid leukemia differ in their engraftment potential in NOD/SCID mice.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  123. ROBAK T
    How to improve the treatment outcome in chronic lymphocytic leukemia?
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  124. BRUEY JM , Kantarjian H, Estrov Z, Zhang Z, et al
    Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  125. FIEDLER W , Mesters R, Heuser M, Ehninger G, et al
    An open-label, Phase I study of cediranib (RECENTIN) in patients with acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  126. GHOSN MG , Haddad AC, Nassar MN, Abadjian GA, et al
    Acute myeloid leukemia and Langerhans' cell histiocytosis: Multiple theories for an unusual presentation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  127. SHINOHARA A , Ichikawa M, Ueda K, Takahashi T, et al
    A novel MLL-AF1p/Eps15 fusion variant in therapy-related acute lymphoblastic leukemia, lacking the EH-domains.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  128. NGUYEN-KHAC F , Barin C, Chapiro E, Macintyre EA, et al
    Cyclin D3 deregulation by juxtaposition with IGH locus in a t(6;14)(p21;q32)-positive T-cell acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  129. YOKOHAMA A , Mishra A, Mitsui T, Becknell B, et al
    A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  130. DREXLER HG , Dirks WG, Macleod RA
    Many are called MDS cell lines: one is chosen.
    Leuk Res. 2009;33:1011-6.
    PubMed     Text format     Related articles    Abstract available


  131. GILES FJ
    Laromustine: the return of alkylators to non-myeloablative therapy of AML.
    Leuk Res. 2009;33:1022-3.
    PubMed     Text format     Related articles   


  132. ZHANG SJ , Shi JY, Li JY
    GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
    Leuk Res. 2009;33:1141-3.
    PubMed     Text format     Related articles    Abstract available


  133. MORRIS KL , Adams JA, Liu Yin JA
    Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.
    Leuk Res. 2009;33:1096-9.
    PubMed     Text format     Related articles    Abstract available


  134. LAIBE S , Tadrist Z, Arnoulet C, Sainty D, et al
    A myeloproliferative disorder may hide another one.
    Leuk Res. 2009;33:1133-6.
    PubMed     Text format     Related articles    Abstract available


  135. CERCHIONE C , Fabbricini R, Pane F, Luciano L, et al
    Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.
    Leuk Res. 2009;33:e104-5.
    PubMed     Text format     Related articles   


  136. ZUNA J , Prouzova Z, Kalina T, Lizcova L, et al
    Backtracking of ALL to cord blood.
    Leuk Res. 2009;33:e107-8.
    PubMed     Text format     Related articles   


  137. ZHENG GH , Fu JR, Xu YH, Jin XQ, et al
    Screening and cloning of multi-drug resistant genes in HL-60/MDR cells.
    Leuk Res. 2009;33:1120-3.
    PubMed     Text format     Related articles    Abstract available


  138. PEHLIVAN M , Sercan Z, Sercan HO
    sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
    Leuk Res. 2009;33:1062-7.
    PubMed     Text format     Related articles    Abstract available


  139. LANCET JE , Baer MR, Duran GE, List AF, et al
    A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
    Leuk Res. 2009;33:1055-61.
    PubMed     Text format     Related articles    Abstract available


  140. VON GOESSEL H , Jacobs U, Semper S, Krumbholz M, et al
    Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009;33:1082-8.
    PubMed     Text format     Related articles    Abstract available


  141. HASEGAWA M , Kurata M, Yamamoto K, Yoshida K, et al
    A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70.
    Leuk Res. 2009;33:1100-7.
    PubMed     Text format     Related articles    Abstract available


  142. CHEN S , Han YH, Zheng Y, Zhao M, et al
    NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells.
    Leuk Res. 2009;33:1108-13.
    PubMed     Text format     Related articles    Abstract available


  143. YE X , Liu T, Gong Y, Zheng B, et al
    Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1.
    Leuk Res. 2009;33:1114-9.
    PubMed     Text format     Related articles    Abstract available


  144. CHEVALLIER P , Hunault-Berger M, Larosa F, Dauriac C, et al
    A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.
    Leuk Res. 2009;33:1124-6.
    PubMed     Text format     Related articles    Abstract available


  145. LITZOW MR
    TKIs and transplant for chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  146. YEOH AE , Lu Y, Chan JY, Chan YH, et al
    Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    July 2009
  147. ALES M , Scaramucci L, Niscola P, Giovannini M, et al
    IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: An exceptionally rare observation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  148. CAPRIA S , Trisolini SM, Matturro A, Santini L, et al
    Acute myeloid leukemia and ischemic heart disease successful first line treatment with clofarabine as single agent.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  149. MANCINI M , Corradi V, Petta S, Martinelli G, et al
    mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  150. SALOMON O , Tohami T, Trakhtenbrot L, Meirov R, et al
    BCR-ABL transcripts are not detected in cord blood or the peripheral blood of the newborn child whose mother developed chronic myeloid leukemia while pregnant.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  151. MANSUR MB , Emerenciano M, Splendore A, Brewer L, et al
    T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  152. MANSHA M , Carlet M, Ploner C, Gruber G, et al
    Functional analyses of Src-like adaptor (SLA), a glucocorticoid-regulated gene in acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  153. CHEN B , Ma Y, Xu X, Wang X, et al
    Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  154. VORA S , Ellis N, Onel K
    Translating genetic questions into clinical answers in acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  155. MAFFEI R , Martinelli S, Castelli I, Santachiara R, et al
    Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  156. BRECCIA M , Alimena G
    Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  157. SUN Y , Cook JR
    Fluorescence in situ hybridization for del(5q) in myelodysplasia/acute myeloid leukemia: Comparison of EGR1 vs. CSF1R probes and diagnostic yield over metaphase cytogenetics alone.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  158. BENETATOS L , Hatzimichael E, Dasoula A, Dranitsaris G, et al
    CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  159. SAWADA A , Sakata N, Kishimoto T, Higuchi B, et al
    Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  160. CAMPIOTTI L , Appio L, Solbiati F, Ageno W, et al
    JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  161. SEFTEL MD , Demers AA, Banerji V, Gibson SB, et al
    High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  162. UCHIYAMA M , Ikeda T
    Successful imatinib mesylate therapy for acquired von Willebrand syndrome in chronic myelogenous leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  163. KLAMOVA H , Markova M, Moravcova J, Siskova M, et al
    Response to treatment in women with chronic myeloid leukemia during pregnancy and after delivery.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  164. VANHEES K , de Bock L, van Schooten FJ, Doorn-Khosrovani SB, et al
    The role of estrogenic compounds in the etiology of pediatric leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  165. RIBATTI D , Crivellato E, Molica S
    Mast cells and angiogenesis in haematological malignancies.
    Leuk Res. 2009;33:876-9.
    PubMed     Text format     Related articles    Abstract available


  166. BRECCIA M , Alimena G
    The metabolic consequences of imatinib mesylate: Changes on glucose, lypidic and bone metabolism.
    Leuk Res. 2009;33:871-5.
    PubMed     Text format     Related articles    Abstract available


  167. VON BONIN M , Hochauf K, Monecke S, Radke J, et al
    Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.
    Leuk Res. 2009;33:e88-90.
    PubMed     Text format     Related articles   


  168. WANG YH , Takanashi M, Tsuji K, Tanaka N, et al
    Level of DNA topoisomerase IIalpha mRNA predicts the treatment response of relapsed acute leukemic patients.
    Leuk Res. 2009;33:902-7.
    PubMed     Text format     Related articles    Abstract available


  169. BERKOZ M , Yalin S
    Association of CYP2B6 G15631T polymorphism with acute leukemia susceptibility.
    Leuk Res. 2009;33:919-23.
    PubMed     Text format     Related articles    Abstract available


  170. KAMIOKA M , Imamura J, Komatsu N, Daibata M, et al
    Testican 3 expression in adult T-cell leukemia.
    Leuk Res. 2009;33:913-8.
    PubMed     Text format     Related articles    Abstract available


  171. GRAMMATICO S , Elia L, Peluso AL, Pedace L, et al
    Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia.
    Leuk Res. 2009;33:e73-4.
    PubMed     Text format     Related articles   


  172. AKAGI T , Yin D, Kawamata N, Bartram CR, et al
    Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.
    Leuk Res. 2009;33:991-6.
    PubMed     Text format     Related articles    Abstract available


  173. FREITAS RA , Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, et al
    Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Leuk Res. 2009;33:958-63.
    PubMed     Text format     Related articles    Abstract available


  174. PODHORECKA M , Halicka HD, Klimek P, Kowal M, et al
    Thalidomide induces phosphorylation of histone H2AX and increases rate of apoptosis caused by fludarabine in malignant lymphocytes of chronic lymphocytic leukemia in short-term cell cultures.
    Leuk Res. 2009;33:997-1000.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  175. KADERI MA , Mansouri M, Zainuddin N, Cahill N, et al
    Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  176. KUBO Y , Kakazu N, Tasaka T, Oka D, et al
    Acute lymphoblastic leukemia (ALL) with t(8;14)(q11.2;q32) in an elderly patient.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  177. AUSTIN C
    Does oxidative damage contribute to the generation of leukemia?
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  178. CHEN W , Huang Q
    Detection of FLT3/ITD, JAK2(V617F) and NPM1 gene mutations in chronic myelomonocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  179. BALDAZZI C , Luatti S, Marzocchi G, Stacchini M, et al
    Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  180. MOON JH , Sohn SK, Lee MH, Jang JH, et al
    BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  181. LIU YL , Castleberry RP, Emanuel PD
    Author's response to the comments on "PTEN deficiency is a common defect in juvenile myelomonocytic leukemia" [Leuk. Res. (2008) (Epub November 17)].
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  182. SHIMIZU T , Kuromi A, Takeda K
    Synergistic induction of gene expression during the differentiation into mature macrophage in human myeloblastic leukemia cells treated with TPA and KH1060.
    Leuk Res. 2009;33:803-9.
    PubMed     Text format     Related articles    Abstract available


  183. BOHNE A , Schlee C, Mossner M, Thibaut J, et al
    Epigenetic control of differential expression of specific ERG isoforms in acute T-lymphoblastic leukemia.
    Leuk Res. 2009;33:817-22.
    PubMed     Text format     Related articles    Abstract available


  184. JIN J , Chen H, Cao L
    Management of conjunctival chemosis secondary to imatinib treatment for chronic myelogenous leukemia.
    Leuk Res. 2009;33:e18-9.
    PubMed     Text format     Related articles   


  185. BATAR B , Guven M, Baris S, Celkan T, et al
    DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
    Leuk Res. 2009;33:759-63.
    PubMed     Text format     Related articles    Abstract available


  186. BURGER JA
    CXCR4 in acute myelogenous leukemia (AML): when too much attraction is bad for you.
    Leuk Res. 2009;33:747-8.
    PubMed     Text format     Related articles   


  187. RADOJKOVIC M , Ristic S, Pavlovic S, Colovic M, et al
    Molecular response to imatinib in patient with Ph negative p190 BCR-ABL transcript positive chronic myeloid leukemia with cyclic leukocytosis.
    Leuk Res. 2009;33:e10-2.
    PubMed     Text format     Related articles    Abstract available


  188. PEPPER CJ
    T-cells in CLL: victims or villains?
    Leuk Res. 2009;33:752.
    PubMed     Text format     Related articles   


  189. TAVERNIER-TARDY E , Cornillon J, Campos L, Flandrin P, et al
    Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.
    Leuk Res. 2009;33:764-8.
    PubMed     Text format     Related articles    Abstract available


  190. STAGNO F , Vigneri P, Del Fabro V, Stella S, et al
    Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
    Leuk Res. 2009;33:e17.
    PubMed     Text format     Related articles   


  191. BJORK J , Johansson B, Broberg K, Albin M, et al
    Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study.
    Leuk Res. 2009;33:788-91.
    PubMed     Text format     Related articles    Abstract available


  192. DE LA IGLESIA INIGO S , Lopez-Jorge CE, Gomez-Casares MT, Lemes Castellano A, et al
    Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents.
    Leuk Res. 2009;33:810-6.
    PubMed     Text format     Related articles    Abstract available


  193. LIN JP , Yang JS, Lu CC, Chiang JH, et al
    Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo.
    Leuk Res. 2009;33:823-8.
    PubMed     Text format     Related articles    Abstract available


  194. RYNINGEN A , Stapnes C, Lassalle P, Corbascio M, et al
    A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid.
    Leuk Res. 2009;33:779-87.
    PubMed     Text format     Related articles    Abstract available


  195. DVORAK P , Hruba M, Subrt I
    Development of acute myeloid leukemia associated with Ph-negative clone with inv(3)(q21q26) during imatinib therapy for chronic myeloid leukemia.
    Leuk Res. 2009;33:860-1.
    PubMed     Text format     Related articles   


  196. COSTELLO RT
    Reversing the multidrug resistance in acute leukemia: until the leukemia initiating cell?
    Leuk Res. 2009;33:749.
    PubMed     Text format     Related articles    Abstract available


  197. MARCELLETTI JF , Multani PS, Lancet JE, Baer MR, et al
    Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
    Leuk Res. 2009;33:769-74.
    PubMed     Text format     Related articles    Abstract available


  198. MATSUE K , Aoki T, Odawara J, Kimura S, et al
    Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Leuk Res. 2009;33:867-9.
    PubMed     Text format     Related articles   


  199. SORA F , De Matteis S, Bajer J, D'alo F, et al
    Persistence of molecular remission throughout pregnancy in CML after imatinib.
    Leuk Res. 2009;33:e6-7.
    PubMed     Text format     Related articles   


  200. PAMUK GE , Puyan FO, Unlu E, Ozturk E, et al
    The first case of de novo B-cell prolymphocytic leukemia with central nervous system involvement: description of an unreported complication.
    Leuk Res. 2009;33:864-7.
    PubMed     Text format     Related articles   


  201. REUTENAUER S , Albucher JF, Pariente J, Dumas H, et al
    Posterior reversible encephalopathy syndrome: two cases in young adults with acute lymphoblastic leukemia.
    Leuk Res. 2009;33:e1-3.
    PubMed     Text format     Related articles   


  202. EISELE L , Haddad T, Sellmann L, Duhrsen U, et al
    Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.
    Leuk Res. 2009;33:775-8.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  203. VERONESE L , Tournilhac O, Verrelle P, Davi F, et al
    Strong correlation between VEGF and MCL-1 mRNA expression levels in B-cell chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  204. AU WY , Yeung CK
    Acute promyelocytic leukemia in patients with severe psoriasis vulgaris.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  205. JAIN S , Naithani R, Kapoor G, Nath T, et al
    l-Asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  206. BATZ C , Sandrock I, Niemeyer CM, Flotho C, et al
    Methylation of the PTEN gene CpG island is infrequent in juvenile myelomonocytic leukemia: Comments on "PTEN deficiency is a common defect in juvenile myelomonocytic leukemia" [Leuk. Res. 2009;33:671-677 (Epub 2008 November 17)].
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  207. BRECCIA M , Palandri F, Iori AP, Colaci E, et al
    Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  208. WANG HP , Xu H, Chen ZM, Tong XM, et al
    t(X;17) as the sole karyotypic anomaly in a case of M(3r) subtype of acute promyelocytic leukemia without RARalpha rearrangement.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  209. FRANK NY , Frank MH
    ABCB5 gene amplification in human leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  210. LO TC , Barnhill LM, Kim Y, Nakae EA, et al
    Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  211. OLIVIERI A , Attolico I, Cimminiello M, Discepoli G, et al
    Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: A case report.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  212. AKAO Y , Nakagawa Y, Iio A, Naoe T, et al
    Role of microRNA-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  213. HARTMAN A , van Schaik RH, van der Heiden IP, Broekhuis MJ, et al
    Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  214. LAMBROU GI , Vlahopoulos S, Papathanasiou C, Papanikolaou M, et al
    Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  215. ZHANG Y , Wang B, Ye S, Liu S, et al
    Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: Possible association with susceptibility to the disease.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  216. JIANG N , Li H, Wang GS, Zhang J, et al
    Acute leukemia, a rare but fatal complication after liver transplantation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  217. OH SH , Park TS, Kim HR, Lee JY, et al
    Chronic myelogenous leukemia showing biphenotypic blast crisis followed by lineage switch to B lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  218. SONG MK , Chung JS, Seol YM, Kim SG, et al
    Mean cell volume can be an early predictor for the cytogenetic response of chronic myeloid leukemia patients treated with imatinib?
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  219. MAGNI M , Di Nicola M, Testi A, Cabras A, et al
    Radioimmunotherapy and secondary leukemia: A case report.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  220. SAI S , Nakagawa Y, Sakaguchi K, Okada S, et al
    Differential regulation of 11beta-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  221. AFTIMOS P , Nasr F
    Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: Case report and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  222. BALLEISEN S , Kuendgen A, Hildebrandt B, Haas R, et al
    Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  223. IRONS RD , Le A, Bao L, Zhu X, et al
    Characterization of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Shanghai, China: Molecular and cytogenetic characteristics, IgV gene restriction and hypermutation patterns.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  224. ISEKI Y , Imoto A, Okazaki T, Harigae H, et al
    Identification of annexin 1 as a PU.1 target gene in leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  225. CAMPIOTTI L , Uccella S, Appio L, Pallotti F, et al
    JAK2 mutation and atypical chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  226. DREXLER HG , Macleod RA
    Malignant hematopoietic cell lines: In vitro models for the study of plasmacytoid dendritic cell leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  227. XIONG X , Wang M, Wang L, Liu J, et al
    Risk of MDM2 SNP309 alone or in combination with the p53 codon 72 polymorphism in acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  228. MUNKER R , Nordberg ML, Veillon D, Williams BJ, et al
    Characterization of a new myeloid leukemia cell line with normal cytogenetics (CG-SH).
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  229. CILLONI D
    Is WT1 helping the molecular monitoring of minimal residual disease to get easier in acute myeloid leukaemia?
    Leuk Res. 2009;33:603-4.
    PubMed     Text format     Related articles   


  230. BERTZ J , Zang C, Liu H, Wachter M, et al
    Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
    Leuk Res. 2009;33:686-92.
    PubMed     Text format     Related articles    Abstract available


  231. MAYANI H , Flores-Figueroa E, Chavez-Gonzalez A
    In vitro biology of human myeloid leukemia.
    Leuk Res. 2009;33:624-37.
    PubMed     Text format     Related articles    Abstract available


  232. GUO D , Ye J, Dai J, Li L, et al
    Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
    Leuk Res. 2009;33:678-85.
    PubMed     Text format     Related articles    Abstract available


  233. FABER E
    Has the time come for induction and maintenance imatinib therapy in chronic myeloid leukemia?
    Leuk Res. 2009;33:605-6.
    PubMed     Text format     Related articles    Abstract available


  234. BRECCIA M , Cannella L, Stefanizzi C, Santopietro M, et al
    Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease.
    Leuk Res. 2009;33:645-8.
    PubMed     Text format     Related articles    Abstract available


  235. VERSTOVSEK S
    Preclinical and clinical experience with dasatinib in Philadelphia chromosome-negative leukemias and myeloid disorders.
    Leuk Res. 2009;33:617-23.
    PubMed     Text format     Related articles    Abstract available


  236. LIU YL , Castleberry RP, Emanuel PD
    PTEN deficiency is a common defect in juvenile myelomonocytic leukemia.
    Leuk Res. 2009;33:671-7.
    PubMed     Text format     Related articles    Abstract available


  237. SAYED D , Badrawy H, Ali AM, Shaker S, et al
    Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia.
    Leuk Res. 2009;33:655-61.
    PubMed     Text format     Related articles    Abstract available


  238. HIROSAWA M , Nakahara M, Otosaka R, Imoto A, et al
    The p38 pathway inhibitor SB202190 activates MEK/MAPK to stimulate the growth of leukemia cells.
    Leuk Res. 2009;33:693-9.
    PubMed     Text format     Related articles    Abstract available


  239. WALTER RB , Estey EH
    The power of comparative studies.
    Leuk Res. 2009;33:610-2.
    PubMed     Text format     Related articles   


  240. USTUN C , Corless CL, Savage N, Fiskus W, et al
    Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
    Leuk Res. 2009;33:735-41.
    PubMed     Text format     Related articles    Abstract available


  241. ASSEF Y , Rubio F, Colo G, del Monaco S, et al
    Imatinib resistance in multidrug-resistant K562 human leukemic cells.
    Leuk Res. 2009;33:710-6.
    PubMed     Text format     Related articles    Abstract available


  242. COSTELLO RT
    How to restore normal innate antitumor immunity in acute leukemia?
    Leuk Res. 2009;33:613.
    PubMed     Text format     Related articles    Abstract available


  243. YOSHIDA Y , Oguma S, Ohno H
    John Auer and Auer rods; controversies revisited.
    Leuk Res. 2009;33:614-6.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  244. HOSHINO K , Quintas-Cardama A, Radich J, Dai H, et al
    Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  245. CAIROLI R , Ripamonti CB, Beghini A, Granata S, et al
    Total serum tryptase: A predictive marker for KIT mutation in acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  246. CHAPIRO E , Leporrier N, Radford-Weiss I, Bastard C, et al
    Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  247. STAGNO F , Vigneri P, Del Fabro V, Stella S, et al
    Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  248. VALERA ET , Brassesco MS, Germeshausen M, Silveira VD, et al
    Acute lymphoblastic leukemia following severe congenital neutropenia or de novo ALL?
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  249. LEHNE G , Grasmo-Wendler UH, Berner JM, Meza-Zepeda LA, et al
    Upregulation of stem cell genes in multidrug resistant K562 leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  250. MAHON FX , Molimard M
    Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  251. BOJARSKA-JUNAK A , Hus I, Chocholska S, Wasik-Szczepanek E, et al
    BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: Correlation with biological and clinical features.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  252. NAGAI S , Nannya Y, Hangaishi A, Takahashi T, et al
    The race and dose of chemotherapy should be considered for optimizing maintenance therapy for acute promyelocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  253. SUCH E , Cervera J, Valencia A, Garcia-Casado Z, et al
    Absence of mutations in the tyrosine kinase and juxtamembrane domains of C-FMS gene in chronic myelomonocytic leukemia (CMML).
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  254. KONDO T , Tasaka T, Sano F, Matsuda K, et al
    Philadelphia chromosome-positive acute myeloid leukemia (Ph+AML) treated with imatinib mesylate (IM) A report with IM plasma concentration and bcr-abl transcripts.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  255. WANG Y , Xue MX, Wu XH, Tang XW, et al
    Successful treatment of relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia with T315I mutation after haplo-identical hematopoietic stem cell transplantation with donor lymphocyte transfusion and interferon-alpha-2b.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  256. GALLAGHER RE
    Real-time consensus on relapse risk in acute promyelocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  257. LION E , Smits EL, Berneman ZN, Van Tendeloo VF, et al
    Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-gamma secretion by human NK cells.
    Leuk Res. 2009;33:539-46.
    PubMed     Text format     Related articles    Abstract available


  258. HAR-NOY M , Zeira M, Weiss L, Fingerut E, et al
    Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma.
    Leuk Res. 2009;33:525-38.
    PubMed     Text format     Related articles    Abstract available


  259. CHOMEL JC , Sorel N, Bonnet ML, Bertrand A, et al
    Quantitative monitoring of the T315I mutation in patients with chronic myeloid leukemia (CML).
    Leuk Res. 2009;33:551-5.
    PubMed     Text format     Related articles    Abstract available


  260. AU WY , Tam S, Fong BM, Kwong YL, et al
    Oral arsenic treatment of leukemia and the risk of porphyria.
    Leuk Res. 2009;33:598-600.
    PubMed     Text format     Related articles   


  261. POLAKOVA K , Bandzuchova E, Kuba D, Russ G, et al
    Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
    Leuk Res. 2009;33:518-24.
    PubMed     Text format     Related articles    Abstract available


  262. LEE SS , Lee JH, Lee JH, Kim DY, et al
    Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.
    Leuk Res. 2009;33:511-7.
    PubMed     Text format     Related articles    Abstract available


  263. HERNANDEZ-BOLUDA JC , Collado M, Roda D, Amat P, et al
    Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia.
    Leuk Res. 2009;33:589-92.
    PubMed     Text format     Related articles   


  264. WANG X , Liu H, Wu Z, Xu X, et al
    A case of acute promyelocytic leukemia presenting with a nonleukemic granulocytic sarcoma of the ovary, with subsequent development of acute myeloid leukemia associated with t(8;21).
    Leuk Res. 2009;33:580-2.
    PubMed     Text format     Related articles   


  265. KAWAMATA N , Zhang L, Ogawa S, Nannya Y, et al
    Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization.
    Leuk Res. 2009;33:569-71.
    PubMed     Text format     Related articles   


  266. FIANCETTE R , Vincent C, Donnard M, Turlure P, et al
    No effect of PGI2 and TXB2 on the proliferation of immature forms of leukemic blasts.
    Leuk Res. 2009;33:596-8.
    PubMed     Text format     Related articles   


  267. DOLAI TK , Bhargava R, Mahapatra M, Mishra P, et al
    Is imatinib safe during pregnancy?
    Leuk Res. 2009;33:572-3.
    PubMed     Text format     Related articles   


  268. GRISKEVICIUS L , Stulpinas R, Vengalyte I, Saulyte-Trakymiene S, et al
    Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.
    Leuk Res. 2009;33:587-8.
    PubMed     Text format     Related articles   


  269. KUILA N , Sahoo DP, Kumari M, Biswas S, et al
    EVI1, BAALC and AME: prevalence of the secondary mutations in chronic and accelerated phases of chronic myeloid leukemia patients from eastern India.
    Leuk Res. 2009;33:594-6.
    PubMed     Text format     Related articles   


  270. GU W , Hu S, He B, Qiu G, et al
    Metabolites of acute promyelocytic leukemia cells participate in contributing to hypertriglyceridemia induced by all-trans retinoic acid.
    Leuk Res. 2009;33:592-4.
    PubMed     Text format     Related articles   


  271. SRINIVASAN S , Schiffer CA
    Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide.
    Leuk Res. 2009;33:561-4.
    PubMed     Text format     Related articles    Abstract available


  272. FOCOSI D , Maggi F, Pistolesi D, Benedetti E, et al
    Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature.
    Leuk Res. 2009;33:556-60.
    PubMed     Text format     Related articles    Abstract available


  273. MORAVCOVA J , Rulcova J, Polakova KM, Klamova H, et al
    Control genes in international standardization of real-time RT-PCR for BCR-ABL.
    Leuk Res. 2009;33:582-4.
    PubMed     Text format     Related articles   


  274. ALI R , Ozkalemkas F, Kimya Y, Koksal N, et al
    Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil.
    Leuk Res. 2009;33:567-9.
    PubMed     Text format     Related articles   


  275. PAYDAS S
    Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
    Leuk Res. 2009;33:566-7.
    PubMed     Text format     Related articles   


  276. EL KINGE AR , Hatoum HA, Mahfouz RA, Otrock ZK, et al
    Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia.
    Leuk Res. 2009;33:565-6.
    PubMed     Text format     Related articles   


  277. SEKHRI A , Liu D, Rasul M, Ahmed N, et al
    Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


    March 2009
  278. FORREST DL , Trainor S, Brinkman RR, Barnett MJ, et al
    Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  279. CHEN-DEUTSCH X , Garay E, Zhang J, Harrison JS, et al
    c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  280. CHEN JY , Wang MC, Hung WC
    Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  281. SCARAMUCCI L , Niscola P, Fratoni S, Giovannini M, et al
    Multicentric myeloid/NK sarcoma in an aleukemic patient evolved in refractory acute leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  282. ZHANG SJ , Li JY, Zhang JF, Finn J, et al
    The decrease of JAK2 V617F allele burden in leukemia transformation of an elderly patient with myelofibrosis.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  283. ERKELAND SJ , Palande KK, Valkhof M, Gits J, et al
    The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  284. CHEN CJ , Wen YF, Huang PT, Hsu MH, et al
    2-(1-Hydroxethyl)-4,8-dihydrobenzo[1,2-b:5,4-b']dithiophene-4,8-dione (BTP-11) enhances the ATRA-induced differentiation in human leukemia HL-60 cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  285. HUSSEIN K , Tefferi A
    Lenalidomide-induced durable hematological and cytogenetic remission in del(5q)-associated de novo acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  286. LIU H , Wang M, Diao S, Rao Q, et al
    siRNA-mediated down-regulation of iASPP promotes apoptosis induced by etoposide and daunorubicin in leukemia cells expressing wild-type p53.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  287. BAO L , Lu X, Lai Y, Zhang X, et al
    Therapy-related acute myeloid leukemia after successful therapy for acute promyelocytic leukemia with t(15;17): A case report and literature review.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  288. BOELENS J , Lust S, Van Bockstaele F, Van Gele M, et al
    Steroid effects on ZAP-70 and SYK in relation to apoptosis in poor prognosis chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  289. GRINBERG I , Reis A, Ohana A, Taizi M, et al
    Engraftment of human blood malignancies to the turkey embryo: A robust new in vivo model.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  290. ALIMENA G , Breccia M, Latagliata R, Grammatico S, et al
    Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  291. DERWICH K , Sedek L, Meyer C, Pieczonka A, et al
    Infant acute bilineal leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  292. ROSNER M , Fuchs C, Siegel N, Valli A, et al
    New insights into the role of the tuberous sclerosis genes in leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  293. LO A , Gu G, Liu M, Dev VG, et al
    ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  294. MARTIN MG , Payton JE, Link DC
    Dicer and outcomes in patients with acute myeloid leukemia (AML).
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  295. BRENNER H , Gondos A, Pulte D
    Long-term survival in chronic myelocytic leukemia after a first primary malignancy.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  296. LU Y , Huang Q
    A unique lethal blastoid transformation of B-cell chronic lymphocytic leukemia carrying ATM/11q deletion and trisomy 12.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  297. GALE RP , Bennett JM
    Are myelodysplastic syndromes and acute myeloid leukemia one disease?
    Leuk Res. 2009;33:351-4.
    PubMed     Text format     Related articles   


  298. CHAN RJ , Cooper T, Kratz CP, Weiss B, et al
    Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.
    Leuk Res. 2009;33:355-62.
    PubMed     Text format     Related articles    Abstract available


  299. QIN Y , Zhu H, Jiang B, Li J, et al
    Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease.
    Leuk Res. 2009;33:384-90.
    PubMed     Text format     Related articles    Abstract available


  300. ALEXANDER HD
    Further evidence that antigen selection shapes the Ig repertoire in CLL.
    Leuk Res. 2009;33:363-5.
    PubMed     Text format     Related articles   


  301. HAMBLIN TJ
    Non-hemic autoimmunity in CLL.
    Leuk Res. 2009;33:366-7.
    PubMed     Text format     Related articles    Abstract available


  302. CHO EH , Kang SK, Kim SY
    Supplemental results of the detection of splicing variant with c-ABL exon 7 deletion by direct sequencing Comment on "A recurrent splicing variant without c-ABL Exon 7 in Imatinib-resistant patients" by Curvo et al. [Leuk. Res.].
    Leuk Res. 2009;33:505-6.
    PubMed     Text format     Related articles   


  303. PALLASCH CP , Ulbrich S, Brinker R, Hallek M, et al
    Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade.
    Leuk Res. 2009;33:460-4.
    PubMed     Text format     Related articles    Abstract available


  304. POYER F , Coquerel B, Pegahi R, Cazin L, et al
    Secretion of MMP-2 and MMP-9 induced by VEGF autocrine loop correlates with clinical features in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009;33:407-17.
    PubMed     Text format     Related articles    Abstract available


  305. ALONSO-C LM , Trinidad EM, de Garcillan B, Ballesteros M, et al
    Expression profile of Eph receptors and ephrin ligands in healthy human B lymphocytes and chronic lymphocytic leukemia B-cells.
    Leuk Res. 2009;33:395-406.
    PubMed     Text format     Related articles    Abstract available


  306. QIAN SX , Li JY, Hong M, Xu W, et al
    Nonhematological autoimmunity (glomerulosclerosis, paraneoplastic pemphigus and paraneoplastic neurological syndrome) in a patient with chronic lymphocytic leukemia: Diagnosis, prognosis and management.
    Leuk Res. 2009;33:500-5.
    PubMed     Text format     Related articles   


  307. HIRASE C , Maeda Y, Takai S, Kanamaru A, et al
    Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor.
    Leuk Res. 2009;33:450-9.
    PubMed     Text format     Related articles    Abstract available


  308. LEE HS , Lee JH, Hur EH, Lee MJ, et al
    Clinical significance of GSTM1 and GSTT1 polymorphisms in younger patients with acute myeloid leukemia of intermediate-risk cytogenetics.
    Leuk Res. 2009;33:426-33.
    PubMed     Text format     Related articles    Abstract available


  309. REID AG , De Melo VA, Elderfield K, Clark I, et al
    Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.
    Leuk Res. 2009;33:418-25.
    PubMed     Text format     Related articles    Abstract available


  310. JOST E , do O N, Wilop S, Herman JG, et al
    Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia.
    Leuk Res. 2009;33:443-9.
    PubMed     Text format     Related articles    Abstract available


  311. AU WY , Harod KK, Law MF
    Cough mixture abuse, folate deficiency and acute lymphoblastic leukemia.
    Leuk Res. 2009;33:508-9.
    PubMed     Text format     Related articles   


  312. ALI R , Ozkalemkas F, Kimya Y, Koksal N, et al
    Acute leukemia and pregnancy.
    Leuk Res. 2009;33:e26-8.
    PubMed     Text format     Related articles   


  313. MESSMER BT , Raphael BJ, Aerni SJ, Widhopf GF, et al
    Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia.
    Leuk Res. 2009;33:368-76.
    PubMed     Text format     Related articles    Abstract available


  314. CORM S , Berthon C, Imbenotte M, Biggio V, et al
    Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
    Leuk Res. 2009;33:490-4.
    PubMed     Text format     Related articles    Abstract available


  315. ISODA A , Ogawa Y, Matsumoto M, Sawamura M, et al
    Coexistence of paroxysmal nocturnal hemoglobinuria (PNH) and acute lymphoblastic leukemia (ALL): Is PNH a prodrome of ALL?
    Leuk Res. 2009;33:e3-5.
    PubMed     Text format     Related articles   


  316. KIGUCHI T , Tauchi T, Ito Y, Miyazawa K, et al
    Compliance with taking imatinib mesylate in patients with chronic myeloid leukemia in the chronic phase.
    Leuk Res. 2009;33:506-8.
    PubMed     Text format     Related articles   


  317. SCRIDELI CA , de Oliveira FM, Brassesco MS, de Paula Queiroz R, et al
    Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
    Leuk Res. 2009;33:495-9.
    PubMed     Text format     Related articles    Abstract available


  318. SCHALK E , Neum S, Kranz S, Scheinpflug K, et al
    Long-term remission in a patient with BCR/ABL-positive acute myeloid leukaemia on maintenance therapy with imatinib.
    Leuk Res. 2009;33:e6-7.
    PubMed     Text format     Related articles   


  319. HELBIG G , Majewski M, Wieczorkiewicz A, Bober G, et al
    Screening for JAK2 V617F point mutation in patients with hypereosinophilic syndrome-in response to 'Hypereosinophilic syndrome: another face of janus?' by Dahabreh et al. published in Leukemia Research, in press.
    Leuk Res. 2009;33:e1-2.
    PubMed     Text format     Related articles   


    February 2009
  320. KWAN JM , Fialho AM, Kundu M, Thomas J, et al
    Bacterial proteins as potential drugs in the treatment of leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  321. XU Z , Wang M, Wang L, Wang Y, et al
    Aberrant expression of TSC2 gene in the newly diagnosed acute leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  322. TSOU MF , Peng CT, Shih MC, Yang JS, et al
    Benzyl isothiocyanate inhibits murine WEHI-3 leukemia cells in vitro and promotes phagocytosis in BALB/c mice in vivo.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  323. JAMROZIAK K , Robak T
    Inheritance and clinical outcome in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  324. JAKL M , Horacek JM, Jebavy L, Pudil R, et al
    Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  325. SHARMA P , Asthana B, Tyagi S
    Triphenotypic acute leukemia with TRAP-positive blasts: A pathological rarity.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  326. TANIMURA A , Yujiri T, Tanaka Y, Hatanaka M, et al
    The anti-apoptotic role of the unfolded protein response in Bcr-Abl-positive leukemia cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  327. GE W , Ma X, Li X, Wang Y, et al
    B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  328. BENNETT CA , Winters AC, Barretto NN, Hemenway CS, et al
    Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  329. PALUMBO GA , Parrinello N, Fargione G, Cardillo K, et al
    CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  330. METZELER KH , Boeck S, Christ B, Hausmann A, et al
    Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  331. WANG Z , Zhou HJ, Li A, Zhang JL, et al
    The effect of dihydroartemisinin on TfR and VEGF expression in iron overload human myeloid leukemia K562 cells.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  332. NAKAYAMA S , Yokote T, Kobayashi K, Hirata Y, et al
    Macroamylasemia in a patient with acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  333. TEIMORI H , Akbari MT, Bibordi E, Toogeh GR, et al
    Chromosomal abnormalities and prognostic markers of B-cell chronic lymphocytic leukemia in Iranian patients.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  334. ZHAO Y , Wu G, Wu K, Liu L, et al
    Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  335. HOCK BD , Fernyhough LJ, Gough SM, Steinkasserer A, et al
    Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  336. KADDAR T , Chien WW, Bertrand Y, Pages MP, et al
    Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  337. PARK TS , Kim J, Song J, Choi JR, et al
    Non-age related Y chromosome loss in an elderly patient with acute promyelocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  338. AVRAMOULI A , Tsochas S, Mandala E, Katodritou E, et al
    Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  339. HOLSTEIN SA , Stokes JB, Hohl RJ
    Renal failure and recovery associated with second-generation Bcr-Abl kinase inhibitors in imatinib-resistant chronic myelogenous leukemia.
    Leuk Res. 2009;33:344-7.
    PubMed     Text format     Related articles    Abstract available


  340. PARK S , Kim TS, Kim C, Kim S, et al
    Transferrin induces interleukin-18 expression in chronic myeloid leukemia cell line, K-562.
    Leuk Res. 2009;33:315-20.
    PubMed     Text format     Related articles    Abstract available


  341. CHEN KS , Hsiao YC, Kuo DY, Chou MC, et al
    Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells.
    Leuk Res. 2009;33:297-307.
    PubMed     Text format     Related articles    Abstract available


  342. BEESLEY AH , Weller RE, Senanayake S, Welch M, et al
    Receptor mutation is not a common mechanism of naturally occurring glucocorticoid resistance in leukaemia cell lines.
    Leuk Res. 2009;33:321-5.
    PubMed     Text format     Related articles    Abstract available


  343. FORREST DL , Trainor S, Brinkman RR, Barnett MJ, et al
    Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels.
    Leuk Res. 2009;33:271-5.
    PubMed     Text format     Related articles    Abstract available


  344. KOURAKLIS G
    HDAC inhibitors in leukemia: current status and perspectives.
    Leuk Res. 2009;33:207-8.
    PubMed     Text format     Related articles   


  345. NYLANDSTED J
    Extracellular heat shock protein 70: a potential prognostic marker for chronic myeloid leukemia.
    Leuk Res. 2009;33:205-6.
    PubMed     Text format     Related articles   


  346. VALLE M , Plon SE, Rabin KR
    Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.
    Leuk Res. 2009;33:336-9.
    PubMed     Text format     Related articles    Abstract available


  347. YEH CH , Tseng R, Zhang Z, Cortes J, et al
    Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.
    Leuk Res. 2009;33:212-7.
    PubMed     Text format     Related articles    Abstract available


  348. DOS SANTOS MP , Schwartsmann G, Roesler R, Brunetto AL, et al
    Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells.
    Leuk Res. 2009;33:218-21.
    PubMed     Text format     Related articles    Abstract available


  349. OVELAND E , Gjertsen BT, Wergeland L, Selheim F, et al
    Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.
    Leuk Res. 2009;33:276-87.
    PubMed     Text format     Related articles    Abstract available


  350. LEE KM , Ward MH, Han S, Ahn HS, et al
    Paternal smoking, genetic polymorphisms in CYP1A1 and childhood leukemia risk.
    Leuk Res. 2009;33:250-8.
    PubMed     Text format     Related articles    Abstract available


  351. CHANG H , Qi X, Yeung J, Reece D, et al
    Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Leuk Res. 2009;33:259-62.
    PubMed     Text format     Related articles    Abstract available


  352. ROGALINSKA M , Goralski P, Wozniak K, Bednarek JD, et al
    Calorimetric study as a potential test for choosing treatment of B-cell chronic lymphocytic leukemia.
    Leuk Res. 2009;33:308-14.
    PubMed     Text format     Related articles    Abstract available


  353. XU W , Li JY, Wu YJ, Yu H, et al
    CD38 as a prognostic factor in Chinese patients with chronic lymphocytic leukaemia.
    Leuk Res. 2009;33:237-43.
    PubMed     Text format     Related articles    Abstract available


  354. SHANAFELT TD , Bowen DA, Venkat C, Slager SL, et al
    The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia.
    Leuk Res. 2009;33:263-70.
    PubMed     Text format     Related articles    Abstract available


  355. ALHAN C , Westers TM, Ossenkoppele GJ, van de Loosdrecht AA, et al
    Do peripheral blasts count in myelodysplastic syndromes?
    Leuk Res. 2009;33:209-11.
    PubMed     Text format     Related articles   


  356. NEUMANN F , Gattermann N, Barthelmes HU, Haas R, et al
    Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
    Leuk Res. 2009;33:232-6.
    PubMed     Text format     Related articles    Abstract available


  357. SAFAIAN NN , Czibere A, Bruns I, Fenk R, et al
    Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.
    Leuk Res. 2009;33:348-50.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  358. MONTILLO M , Ricci F, Tedeschi A, Cafro AM, et al
    Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  359. VARADARAJAN R , Ford L, Sait SN, Block AW, et al
    Metachronous and synchronous presentation of acute myeloid leukemia and lung cancer.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  360. KARAS KUZELICKI N , Milek M, Jazbec J, Mlinaric-Rascan I, et al
    5,10-Methylenetetrahydrofolate reductase (MTHFR) low activity genotypes reduce the risk of relapse-related acute lymphoblastic leukemia (ALL).
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  361. PENARRUBIA MJ , Silvestre LA, Conde J, Cantalapiedra A, et al
    Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  362. CASSINAT B , de Botton S, Kelaidi C, Ades L, et al
    When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group).
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  363. YOGAPARAN T , Panju A, Minden M, Brandwein J, et al
    Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  364. GUASTAFIERRO S , Falcone U, Celentano M, Coppola M, et al
    Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  365. WANG Y , Fang M, Jing Y, Li J, et al
    Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  366. SILVEIRA VD , Canalle R, Scrideli CA, Queiroz RG, et al
    Polymorphisms of xenobiotic metabolizing enzymes and DNA repair genes and outcome in childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  367. SIGALAS P , Tourvas AD, Moulakakis A, Pangalis G, et al
    Nelarabine induced complete remission in an adult with refractory T-lineage acute lymphoblastic leukemia: A case report and review of the literature.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  368. SCRIDELI CA , Tone LG
    Polymorphisms of DNA repair genes and susceptibility to acute childhood lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  369. THORN I , Botling J, Hermansson M, Lonnerholm G, et al
    Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  370. GOTO H , Naruto T, Tanoshima R, Kato H, et al
    Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  371. VAN DEN ANCKER W , Terwijn M, Regelink J, Westers TM, et al
    Uncommon lineage switch warrants immunophenotyping even in relapsing leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


  372. PARK TS , Cheong JW, Song J, Choi JR, et al
    Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia.
    Leuk Res. 2009.
    PubMed     Text format     Related articles    Abstract available


  373. PUNEKAR M , Thachil J, Salim R, Watmough S, et al
    T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors-Clues from and for sarcoidosis.
    Leuk Res. 2009.
    PubMed     Text format     Related articles   


    November 2008
  374. SANCHEZ-GUIJO FM , Lopez-Jimenez J, Gonzalez T, Santamaria C, et al
    Multitargeted sequential therapy with MK-0457 and dasatinib followed by stem cell transplantation for T315I mutated chronic myeloid leukemia.
    Leuk Res. 2008.
    PubMed     Text format     Related articles   


  375. KONUMA T , Ooi J, Takahashi S, Tomonari A, et al
    Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCT.
    Leuk Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  376. RASHEED W , Flaim B, Seymour JF
    Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukemia.
    Leuk Res. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  377. CATALINA P , Bueno C, Montes R, Nieto A, et al
    Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia.
    Leuk Res. 2008.
    PubMed     Text format     Related articles    Abstract available


  378. TABACZEWSKI P , Nadesan S, Lim SH
    Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: A common defective stem cell?
    Leuk Res. 2008.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: